Cambium Bio Limited
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye (NCT06903611) | Cambium Bio Limited | 2026-10-01 |
Track Cambium Bio Limited automatically
Every clearance here is in the API, with alerts when new ones post.